Skip to main content
Top
Published in: Journal of Clinical Immunology 4/1998

01-07-1998

Expression of Properdin in Complete and Incomplete Deficiency: Normal in Vitro Synthesis by Monocytes in Two Cases with Properdin Deficiency Type II Due to Distinct Mutations

Authors: Gunilla Nordin Fredrikson, Birgitta Gullstrand, Joakim Westberg, Anders G. Sjöholm, Mathias Uhlén, Lennart Truedsson

Published in: Journal of Clinical Immunology | Issue 4/1998

Login to get access
Metadata
Title
Expression of Properdin in Complete and Incomplete Deficiency: Normal in Vitro Synthesis by Monocytes in Two Cases with Properdin Deficiency Type II Due to Distinct Mutations
Authors
Gunilla Nordin Fredrikson
Birgitta Gullstrand
Joakim Westberg
Anders G. Sjöholm
Mathias Uhlén
Lennart Truedsson
Publication date
01-07-1998
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Journal of Clinical Immunology / Issue 4/1998
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1023/A:1027385806871

Other articles of this Issue 4/1998

Journal of Clinical Immunology 4/1998 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.